Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy

INTRODUCTION: Despite the recognized importance of atrophy in multiple sclerosis (MS), methods for its quantification have been mostly restricted to the research domain. Recently, a CE labelled and FDA approved MS-specific atrophy quantification method, MSmetrix, has become commercially available. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Steenwijk, Martijn D., Amiri, Houshang, Schoonheim, Menno M., de Sitter, Alexandra, Barkhof, Frederik, Pouwels, Petra J.W., Vrenken, Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540882/
https://www.ncbi.nlm.nih.gov/pubmed/28794970
http://dx.doi.org/10.1016/j.nicl.2017.06.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540882/
https://www.ncbi.nlm.nih.gov/pubmed/28794970
http://dx.doi.org/10.1016/j.nicl.2017.06.034

Ejemplares similares